249 related articles for article (PubMed ID: 27725227)
1. Targeting p38 MAP kinase signaling in cancer through post-translational modifications.
Zou X; Blank M
Cancer Lett; 2017 Jan; 384():19-26. PubMed ID: 27725227
[TBL] [Abstract][Full Text] [Related]
2. Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?
Rovida E; Stecca B
Semin Cancer Biol; 2015 Dec; 35():154-67. PubMed ID: 26292171
[TBL] [Abstract][Full Text] [Related]
3. The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer.
Yong HY; Koh MS; Moon A
Expert Opin Investig Drugs; 2009 Dec; 18(12):1893-905. PubMed ID: 19852565
[TBL] [Abstract][Full Text] [Related]
4. p38 MAP kinase: a convergence point in cancer therapy.
Olson JM; Hallahan AR
Trends Mol Med; 2004 Mar; 10(3):125-9. PubMed ID: 15102355
[TBL] [Abstract][Full Text] [Related]
5. Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard.
Yego EC; Dillman JF
Toxicol In Vitro; 2013 Oct; 27(7):2067-75. PubMed ID: 23851002
[TBL] [Abstract][Full Text] [Related]
6. p38-MAPK/MSK1-mediated overexpression of histone H3 serine 10 phosphorylation defines distance-dependent prognostic value of negative resection margin in gastric cancer.
Khan SA; Amnekar R; Khade B; Barreto SG; Ramadwar M; Shrikhande SV; Gupta S
Clin Epigenetics; 2016; 8(1):88. PubMed ID: 27588146
[TBL] [Abstract][Full Text] [Related]
7. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.
Polivka J; Janku F
Pharmacol Ther; 2014 May; 142(2):164-75. PubMed ID: 24333502
[TBL] [Abstract][Full Text] [Related]
8. PKD, PKD2, and p38 MAPK mediate Hsp27 serine-82 phosphorylation induced by neurotensin in pancreatic cancer PANC-1 cells.
Yuan J; Rozengurt E
J Cell Biochem; 2008 Feb; 103(2):648-62. PubMed ID: 17570131
[TBL] [Abstract][Full Text] [Related]
9. The p53 pathway is synergized by p38 MAPK signaling to mediate 11,11'-dideoxyverticillin-induced G2/M arrest.
Chen Y; Miao ZH; Zhao WM; Ding J
FEBS Lett; 2005 Jul; 579(17):3683-90. PubMed ID: 15963507
[TBL] [Abstract][Full Text] [Related]
10. p38 MAPK: a potential target of chronic pain.
Lin X; Wang M; Zhang J; Xu R
Curr Med Chem; 2014; 21(38):4405-18. PubMed ID: 25245374
[TBL] [Abstract][Full Text] [Related]
11. Signal transduction pathways in Burkitt's lymphoma cell lines BL41 and DG75 with different sensitivity to doxorubicin.
Shlapatska LM; Berdova GG; Kovalevska LM; Kulyk GI; Klein G; Sidorenko SP; Chekhun VF
Exp Oncol; 2004 Sep; 26(3):210-6. PubMed ID: 15494689
[TBL] [Abstract][Full Text] [Related]
12. p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents.
Sui X; Kong N; Ye L; Han W; Zhou J; Zhang Q; He C; Pan H
Cancer Lett; 2014 Mar; 344(2):174-9. PubMed ID: 24333738
[TBL] [Abstract][Full Text] [Related]
13. The p38 Pathway: From Biology to Cancer Therapy.
Martínez-Limón A; Joaquin M; Caballero M; Posas F; de Nadal E
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32168915
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors.
Gupta J; Igea A; Papaioannou M; Lopez-Casas PP; Llonch E; Hidalgo M; Gorgoulis VG; Nebreda AR
Oncotarget; 2015 Apr; 6(11):8539-51. PubMed ID: 25890501
[TBL] [Abstract][Full Text] [Related]
15. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.
Weldon CB; Parker AP; Patten D; Elliott S; Tang Y; Frigo DE; Dugan CM; Coakley EL; Butler NN; Clayton JL; Alam J; Curiel TJ; Beckman BS; Jaffe BM; Burow ME
Int J Oncol; 2004 Jun; 24(6):1473-80. PubMed ID: 15138590
[TBL] [Abstract][Full Text] [Related]
16. PPM1G promotes the progression of lung adenocarcinoma by inhibiting p38 activation via dephosphorylation of MEK6.
Chen J; Li J; Sun H; Hu T; Wang Y; Kang G; Cao M; Li X
Carcinogenesis; 2023 May; 44(1):93-104. PubMed ID: 36349938
[TBL] [Abstract][Full Text] [Related]
17. Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
Otto KB; Acharya SS; Robinson VL
Urol Oncol; 2012; 30(4):415-20. PubMed ID: 22154358
[TBL] [Abstract][Full Text] [Related]
18. The Stress Kinase p38α as a Target for Cancer Therapy.
Igea A; Nebreda AR
Cancer Res; 2015 Oct; 75(19):3997-4002. PubMed ID: 26377941
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of heat shock protein 27 antagonizes TNF-α induced HeLa cell apoptosis via regulating TAK1 ubiquitination and activation of p38 and ERK signaling.
Qi Z; Shen L; Zhou H; Jiang Y; Lan L; Luo L; Yin Z
Cell Signal; 2014 Jul; 26(7):1616-25. PubMed ID: 24686082
[TBL] [Abstract][Full Text] [Related]
20. Targeting cancer with kinase inhibitors.
Gross S; Rahal R; Stransky N; Lengauer C; Hoeflich KP
J Clin Invest; 2015 May; 125(5):1780-9. PubMed ID: 25932675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
